CMO Paul Kelly responds to debate over the AstraZeneca vaccine saying Australia is choosing the drug that is ‘available to give the maximum rollout’ and ‘save lives’.
SOURCE: Medical Research – Read entire story here.
Real time coverage of developments and trends in health care
Published
CMO Paul Kelly responds to debate over the AstraZeneca vaccine saying Australia is choosing the drug that is ‘available to give the maximum rollout’ and ‘save lives’.
SOURCE: Medical Research – Read entire story here.